APPLICATION OF NGS AND MLPA METHODS FOR THE DETECTION OF PATHOGENIC VARIANTS IN THE BRCA1/2 GENES IN AZERBAIJANI PATIENTS WITH BREAST CANCER
Proceedings of the Institute of Genetic Resources of the Ministry of Science and Education Republic of Azerbaijan · 2026 · 15 (2)
DOI: 10.61642/2026214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the Institute of Genetic Resources of the Ministry of Science and Education Republic of Azerbaijan, 2026. Verfasst von Zumrud Safarzade.
Abstract (Originalsprache)
Hereditary mutations in the BRCA1 and BRCA2 genes are among the key factors in the development of breast and ovarian cancer and are associated with a high lifetime risk of oncological disease. Impairment of these genes, which are involved in homologous recombination repair of DNA double-strand breaks, leads to genomic instability and an increased likelihood of malignant cell transformation. Furthermore, the identification of germline mutations has important clinical significance, as it determines sensitivity to targeted therapies, including PARP inhibitors and platinum-based agents. The aim of the present study was to perform a molecular genetic analysis of the BRCA1 and BRCA2 genes in patients with breast cancer and to evaluate the diagnostic effectiveness of the combined use of next-generation sequencing (NGS) and MLPA methods. The study included 148 patients aged 22 to 90 years (mean age at manifestation — 58 years) who underwent examination and treatment between 2017 and 2023. All patients received primary molecular genetic testing, and 17 patients with a triple-negative tumor phenotype underwent extended analysis using NGS, followed by MLPA to exclude large genomic rearrangements. Library preparation was performed using a targeted panel, and sequencing was carried out on the MiSeq platform with an average coverage depth of 100×. The interpretation of identified variants was conducted in accordance with ACMG guidelines, using international databases and pathogenicity prediction tools. As a result, no pathogenic or likely pathogenic variants were detected in 14 of the 17 examined patients (82.4%). Clinically significant alterations were identified in 3 patients (17.6%), including a missense variant, nonsense mutations, and a heterozygous frameshift deletion, potentially leading to premature termination of translation and loss of protein function. No large deletions or duplications were detected by MLPA. The obtained data confirm the high diagnostic value of the combined NGS+MLPA approach and highlight the need for further studies to clarify the frequency and mutation spectrum in the Azerbaijani population.
Zitieren
APA
Safarzade, Z. (2026). APPLICATION OF NGS AND MLPA METHODS FOR THE DETECTION OF PATHOGENIC VARIANTS IN THE BRCA1/2 GENES IN AZERBAIJANI PATIENTS WITH BREAST CANCER. Proceedings of the Institute of Genetic Resources of the Ministry of Science and Education Republic of Azerbaijan, 15(2). https://doi.org/10.61642/2026214
Vancouver
Safarzade Z. APPLICATION OF NGS AND MLPA METHODS FOR THE DETECTION OF PATHOGENIC VARIANTS IN THE BRCA1/2 GENES IN AZERBAIJANI PATIENTS WITH BREAST CANCER. Proceedings of the Institute of Genetic Resources of the Ministry of Science and Education Republic of Azerbaijan. 2026;15(2). doi:10.61642/2026214
BibTeX
@article{Safarzade2026,
author = {Safarzade, Zumrud},
title = {APPLICATION OF NGS AND MLPA METHODS FOR THE DETECTION OF PATHOGENIC VARIANTS IN THE BRCA1/2 GENES IN AZERBAIJANI PATIENTS WITH BREAST CANCER},
journal = {Proceedings of the Institute of Genetic Resources of the Ministry of Science and Education Republic of Azerbaijan},
year = {2026},
volume = {15},
number = {2},
doi = {10.61642/2026214}
}
EUVIMED